Piper Sandler raised the firm’s price target on Omnicell (OMCL) to $57 from $46 and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell’s Positive Outlook: Buy Rating Supported by Favorable Tariff Changes and Stock Repurchase Program
- Omnicell price target raised to $34 from $30 at BofA
- Omnicell price target raised to $37 from $35 at Wells Fargo
- Omnicell’s Enhanced Profitability and Strategic Initiatives Drive Buy Rating with Increased Price Target
- Omnicell Updates 2025 Guidance and Stock Buyback Plan